Angiotensin II Type 1 Receptor Blocker, Fimasartan, Reduces Vascular Smooth Muscle Cell Senescence by Inhibiting the CYR61 Signaling Pathway
Inho Kim(Seoul National University), Hae‐Young Lee(Seoul National University Hospital)
Cited by 17
Related Papers
Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension
|Journal of Hypertension|2023|245
Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction
|Journal of the American Heart Association|2019|113
Validation of a wearable cuff-less wristwatch-type blood pressure monitoring device
|Scientific Reports|2020|54
Neuroprotective effects of Scrophularia buergeriana extract against glutamate-induced toxicity in SH-SY5Y cells
|International Journal of Molecular Medicine|2019|47